1 / 16 Next Page
Information
Show Menu
1 / 16 Next Page
Page Background

Readers Poll

Would you like

to join Elsevier’s

Medical Advisory

Board?

Scan this code

or go to

goo.gl/lwmfJy

to have

your say in

this issue’s

PracticeUpdate

Cardiology

Readers Poll.

CONFERENCE

COVERAGE

2016 ESC Congress

CPAP is shown to improve

wellbeing but not

cardiovascular outcomes

5

Lipoprotein(a) apheresis

proves beneficial in

refractory angina

8

CORONARY HEART

DISEASE

Benefits of omega-3 fatty

acids from fish oil after acute

MI: an off and on affair?

9

MYOCARDIAL

DISEASE

The pivotal position of IL-6 in

the pathogenesis of ischaemic

heart disease, and a lot of

new questions

12

ARRHYTHMIAS/

HEARTRHYTHM

DISORDERS

My approach to atrial fibrillation:

rate vs rhythm control

15

Comparison of inhospital mortality

and frequency of coronary

angiography on weekend versus

weekday admissions in patients

with non-ST-segment elevation

acute myocardial infarction

American Journal of Cardiology

Admission on a weekend was

associated with higher inhospital

mortality compared with admission

on a weekday.

9

Hypochloraemia,

diuretic resistance,

and outcome in patients

with acute heart failure

Circulation: Heart Failure

Data indicated that chloride

measurement in acute HF patients

at admission and at 14 days could

be used as a marker for response to

therapy and outcome.

11

Diagnostic performance

of a smartphone-based

photoplethysmographic application

for atrial fibrillation screening in a

primary care setting

Journal of the American Heart Association

The smartphone PPG application

Cardiio Rhythm detected AF in

patients at risk of developing AF and

could be used to enable population-

based screening for AF.

14

Development and validation

of a sudden cardiac death

prediction model for the general

population

Circulation

This new risk equation provides

slightly better predictive ability for

SCD than the ACC/AHA model and

is generalisable to the

US population without

cardiovascular disease.

15

Implantable

cardioverter-

defibrillator does

not improve

overall survival

in nonischaemic

heart failure

App-based

technology for

diagnosing AF

is definitely

cool; however,

chasing AF in a

low-risk patient

in the absence

of an integrated

program to

manage false–

positive results

may send us

chasing the elusive

Pokemon!

14

OPINION

Placement of an implantable

cardioverter-defibrillator in

patients with nonischaemic

systolic heart failure did

not improve overall survival

compared with usual clinical

care. Risk of sudden cardiac

death, however, was halved,

reports the DANISH trial.

4

RESEARCH NEWS AND VIEWS FROM ELSEVIER

VOL. 1 • No. 2 • 2016

ISSN 2206-4672